Proteinosis alveolar
Alveolar proteinosis
Contenido principal del artículo
Resumen
Palabras clave:
Descargas
Detalles del artículo
Referencias (VER)
Rosen SH, Castleman B, Liebbow AA. Pulmonary alveolar proteinosis. N Engl J Med. 1958; 258:1124-42.
Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis:progress in the first 44 years. Am J Respir Crit Care Med.2002;166:215-35.
Larson RK, Gordinier R. Pulmonary alveolar proteinosis: report of six cases, review of the literature, and formulation of a new theory. Ann Intern Med. 1965;62:292-312.
Kumar V, Abbas AK, Fausto N, Aster JC. Robbins y Cotran.Patología estructural y funcional, 7a ed. Ed. Elsevier; 2007.p. 745-6.
Borie R, Danel C, Debray MP, Taille C, Dombret MC, Aubier M, et al. Pulmonary alveolar proteinosis. Eur Respir Rev.2011; 20:98-107.
Inoue Y, Trapnell BC, Tazawa R, Arai T, Takada T, Hizawa N. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med. 2008;177: 752–62.
Teja K, Cooper PH, Squires JE, Schnatterly PT. Pulmonary alveolar proteinosis in four siblings. N Engl J Med.1981;305(23): 1390-2.
Suzuki T, Sakagami T, Young LR, Carey BC, Wood RE,Luisetti M, et al. Hereditary pulmonary alveolar proteinosis:pathogenesis, presentation, diagnosis, and therapy. Am J Respir Crit Care Med. 2010; 182(10): 1292-304.
Schiller V, Aberle DR, Aberle AM. Pulmonary alveolar proteinosis. Occurrence with metastatic melanoma to lung. Chest.1989; 95(2): 466-7.
Bedrossian CW, Luna MA, Conklin RH, Miller WC. Alveolar proteinosis as a consequence of immunosuppression. A hypothesis based on clinical and pathologic observations. Hum Pathol. 1980;11(5 Suppl):527-35.
Ruben FL, Talamo TS. Secondary pulmonary alveolar proteinosis occurring in two patients with acquired immune deficiency syndrome. Am J Med. 1986;80(6):1187-90.
Keller CA, Frost A, Cagle PT, Abraham JL. Pulmonary alveolar proteinosis in a painter with elevated pulmonary concentrations of titanium. Chest. 1995;108(1):277-80.
Chan ED, King TE. Diagnosis and treatment of pulmonary alveolar proteinosis in adults. Uptodate. [Sede web]. Jun, 2013.Waltham, Massachusetts. com/
Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colonystimulating factor. J Exp Med. 1999;190:875-80.
Paine R, Preston AM, Wilcoxen S, Jin H, Siu BB, Morris SB, et al. Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice. J Immunol. 2000; 164(5): 2602-9.
Kumar V, Abbas AK, Fausto N, Aster JC. Robbins y Cotran. Patología estructural y funcional, 7a ed. Ed. Elsevier; 2007. p. 745-6.
Rodríguez J, Rodríguez E, Sánchez A. Proteinosis alveoloar.Respuesta al tratamiento con factor estimulante de colonias de granulocitos y macrófagos por vía inhalada. Arch Bronconeumol. 2009;45(3):150-2.
Bonella F, Bauer PC, Griese M, Ohshimo S, Guzman J, Costabel U. Pulmonary alveolar proteinosis: new insights from a single-center cohort of 70 patients. Respir Med.2011;105(12):1908-16.
Leth S, Bendstrup E, Vestergaard H, Hilberg O. Autoimmune pulmonary alveolar proteinosis: treatment options in year 2013. Respirology. 2013;18(1):82.
Lin FC, Chang GD, Chern MS, Chen YC,Chang SC. Clinical significance of anti-GMCSF antibodies in idiopathic pulmonary alveolar proteinosis. Thorax. 2006;61:528-34.
Trapnell BC, Uchida K. Pulmonary alveolar proteinosis. Eur Respir Mon. 2009;46(12):208-24.
Huizar I, Kavuru M. Alveolar proteinosis syndrome: pathogenesis, diagnosis and management. Curr Opin Pulm Med.2009;15(5):491-8.
Chan ED, King TE. Diagnosis and treatment of pulmonary alveolar proteinosis in adults. Uptodate. [Sede web]. Jun, 2013.Waltham, Massachusetts.
Vancheeswaran R, Morgan C, Wells A. Pulmonary alveolar proteinosis. Investigation and management –A review. Clin Pulmonary Med. 2007;14(6):360-4.
Kavuru MS, Malur A, Marshall I, Barna BP, Meziane M, Huizar I, et al. An open-label trial of rituximab therapy in pulmonary alveolar proteinosis. Eur Respir J. 2011;38:1361-7.
Tazawa R, Trapnell BC, Inoue Y, Arai T, Takada T, Nasuhara Y, et al. Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 2015;181(12):1345-54.
Beccaria M, Luisetti M, Rodi G, Corsico A, Zoia MC, Colato S, et al. Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. Eur Respir J. 2004;23(4):526-31.
Luisetti M, Rodi G, Perotti C, Campo I, Mariani F, Pozzi E, et al. Plasmapheresis for treatment of pulmonary alveolar proteinosis. Eur Respir J. 2009;33(5):1220-2.
Rodríguez Robles AO, Ángel Ortega M, Valenciano López C, Araújo J, Ortiz Barraza E, Pérez Rodríguez. Proteinosis alveolar y lavado broncoalveolar terapéutico(LBA-T).Tratamiento solo o combinado.Patología Respiratoria.2014;17(2).